Cargando…
肺癌患者静脉血栓栓塞症的发生及其抗凝治疗
Lung cancer is the first leading cause of morbidity and mortality in the world. Venous thromboembolism (VTE) is a recognized complication in patients with lung cancer, which is one of the leading cause of death in lung cancer patients. The cancer-related, patient-related and treatment-related factor...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6189020/ https://www.ncbi.nlm.nih.gov/pubmed/30309431 http://dx.doi.org/10.3779/j.issn.1009-3419.2018.10.09 |
Ejemplares similares
-
胸外科围术期静脉血栓栓塞症专题前言
Publicado: (2018) -
肺癌术后静脉血栓栓塞症相关危险因素分析:单中心研究
Publicado: (2018) -
胸部恶性肿瘤围术期静脉血栓栓塞症预防中国专家共识(2018版)
Publicado: (2018) -
肺癌患者入院时下肢深静脉血栓的发生率及相关危险因素分析
Publicado: (2018) -
肺癌患者围手术期预防性抗凝的临床价值分析
Publicado: (2018)